{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Clinical Vignette:** 70ì„¸ ë…¸ì¸, í†µì¦ ì—†ëŠ” í™©ë‹¬ (Painless Jaundice), Courvoisier's sign (ë§Œì ¸ì§€ëŠ” ë‹´ë‚­).\n    - **Diagnosis:** [Malignancy (Pancreatic head cancer, Cholangiocarcinoma)]\n    - **Key Action:** **CT Abdomen** or **US** first. **Do NOT** assume stones.\n2. **Clinical Vignette:** ì Šì€ í™˜ì, ìŠ¤íŠ¸ë ˆìŠ¤ ë°›ê±°ë‚˜ êµ¶ì—ˆë”ë‹ˆ ê²½ë¯¸í•œ í™©ë‹¬ (Mild unconjugated hyperbilirubinemia). ê°„ìˆ˜ì¹˜ ì •ìƒ.\n    - **Diagnosis:** [Gilbert Syndrome]\n    - **Key Action:** **Reassurance**. No treatment needed.\n3. **Clinical Vignette:** Cirrhosis í™˜ì, Confusion, Asterixis (Hand flapping).\n    - **Diagnosis:** [Hepatic Encephalopathy]\n    - **Key Action:** Check for triggers (Infection, GI bleed, Constipation). Start **Lactulose**.\n4. **Clinical Vignette:** Acute Liver Failure Triad?\n    - **Answer:** [Severe Liver Injury (High LFTs) + Coagulopathy (INR â‰¥ 1.5) + Encephalopathy]\n    - **Trap:** Mental statusê°€ ì •ìƒì´ë©´ Acute Hepatitisì´ì§€ ALFê°€ ì•„ë‹˜! â˜…\n    - Hep C ëŠ” ì›ì¸ì•„ë‹˜! íƒ€ì´ë ˆë†€ì€ ì›ì¸ì„\n5. SAAG >1.1 : High Hydrostatic portal Hypertension / SAAG <1.1 : Low Leaky albumin\n6. **Clinical Vignette:** Ascites í™˜ì, **ë¯¸ì—´ â˜…**  ë°œìƒ. Paracentesisì—ì„œ PMN > 250.\n    - **Diagnosis:** [Spontaneous Bacterial Peritonitis (SBP)]\n    - **Key Action:** Start **Ceftriaxone** immediately. Give **Albumin** to protect kidneys.\n## ğŸ“ Tutor's One-Liner\n\"JaundiceëŠ” **Pain**ì´ ìˆëŠ”ì§€ ë¨¼ì € ë³´ê³ , LFT íŒ¨í„´(**Hepatocellular vs Cholestatic**)ìœ¼ë¡œ ê¸¸ì„ ë‚˜ëˆˆ ë’¤, **Anatomy(Duct dilation)**ë¥¼ í™•ì¸í•˜ì„¸ìš”. CirrhosisëŠ” **Decompensated events**(Bleeding, Ascites, Encephalopathy)ë¥¼ ë§‰ê³  ê´€ë¦¬í•˜ëŠ” ê²ƒì´ ì „ë¶€ì…ë‹ˆë‹¤! íŒŒì´íŒ…! ğŸ’ª\"\n---\n# ğŸ©º **Deep Dive: Liver Pathology (Cirrhosis & Complications)**\n**Section 4.2 - 4.7 Comprehensive Lecture Notes**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ ìš°ë¦¬ëŠ” ìš°ë¦¬ ëª¸ì˜ **Metabolic Engine**ì¸ **Liver**ê°€ ê³ ì¥ ë‚¬ì„ ë•Œ ì–´ë–¤ ì¼ì´ ë²Œì–´ì§€ëŠ”ì§€, ê·¸ë¦¬ê³  **USMLE Step 2 CK**ì—ì„œ ì–´ë–»ê²Œ ì¶œì œë˜ëŠ”ì§€ ì•„ì£¼ ê¹Šê²Œ íŒŒí—¤ì³ ë³¼ ê²ë‹ˆë‹¤. ì—”ì§„ì´ ë©ˆì¶”ë©´ ì‹œìŠ¤í…œ ì „ì²´ê°€ ë¶•ê´´ë˜ë“¯ì´, ê°„ì´ ë©ˆì¶”ë©´ Brain, Kidney, Lungê¹Œì§€ ëª¨ë‘ íƒ€ê²©ì„ ì…ìŠµë‹ˆë‹¤. ì, ì¤€ë¹„ë˜ì…¨ë‚˜ìš”? Let's dive in! ğŸ¤¿","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-146","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"---\n## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\n| **Clinical Vignette (Korean Context)** | **Diagnosis** | **Key Action / Trap / Treatment** |\n| --- | --- | --- |\n| ìˆ  ë§ì´ ë§ˆì‹œëŠ” í™˜ì, ê°€ìŠ´ì— ê±°ë¯¸ì¤„ ëª¨ì–‘ í˜ˆê´€, ì†ë°”ë‹¥ ë¶‰ìŒ, ì—¬ì„±í˜• ìœ ë°© | **Cirrhosis (Stigmata)** | **Mechanism:** Hyperestrogenism (Liver fails to metabolize estrogen) |\n| ë³µìˆ˜ ì²œì(Paracentesis) í–ˆëŠ”ë° **SAAG > 1.1** | **Portal Hypertension** | **Etiology:** Cirrhosis, Heart Failure, Budd-Chiari\nProtein >2.5: CHF, BC\nProtein <2.5: Cirrhosis |\n| ë³µìˆ˜ ì²œì ê²°ê³¼ **Neutrophils (PMN) > 250** | **Spontaneous Bacterial Peritonitis (SBP)** | **Tx:** Ceftriaxone (or Cefotaxime) + **IV Albumin** (Kidney protection!) |\n| ê°„ê²½ë³€ í™˜ì, Creatinine ìƒìŠ¹, ìˆ˜ì•¡ ì¤˜ë„ í˜¸ì „ ì—†ìŒ (FeNa < 1%) | **Hepatorenal Syndrome** | **Tx:** Midodrine + Octreotide + Albumin (Vasoconstrictors!) |\n| ê°„ê²½ë³€ í™˜ì, ê°‘ìê¸° ë©í•´ì§(Confusion), ì†ì„ í„ëŸ­ì„(**Asterixis**) | **Hepatic Encephalopathy** | **Tx:** Lactulose (1st line), Rifaximin (Add-on) |\n| ê°„ê²½ë³€ í™˜ì, ì¼ì–´ë‚˜ ì•‰ìœ¼ë©´ ìˆ¨ì´ ì°¸ (**Platypnea**) | **Hepatopulmonary Syndrome** | **Mechanism:** Pulmonary vasodilation â†’ Shunt |\n| ì Šì€ ì—¬ì„±/Hypercoagulable state, ê¸‰ì„± ë³µí†µ, ë³µìˆ˜, ê°„ë¹„ëŒ€ | **Budd-Chiari Syndrome** | **Dx:** Doppler US (Hepatic vein thrombosis) |\n| ë©•ì‹œì½” ì—¬í–‰ ë‹¤ë…€ì˜´, RUQ pain, Anchovy paste pus, í˜ˆë³€ | **Amebic Liver Abscess** | **Tx:** Metronidazole (**Do NOT drain!**) |\n---\n## 4.2.1 Cirrhosis: The Scarred Engine ğŸ§±\n**Concept:** ê°„ì´ ë§ë‘ë§ë‘í•œ **Sponge**ì—ì„œ ë”±ë”±í•œ **Brick**ìœ¼ë¡œ ë³€í•˜ëŠ” ê³¼ì •ì…ë‹ˆë‹¤. Fibrosisê°€ ì§„í–‰ë˜ë©´ì„œ ê°„ì˜ ëŒ€ì‚¬ ê¸°ëŠ¥(Metabolic function)ê³¼ êµ¬ì¡°ì  ê¸°ëŠ¥(Plumbing)ì´ ëª¨ë‘ ë§ê°€ì§‘ë‹ˆë‹¤.\n### 1. Stigmata of Chronic Liver Disease (Physical Exam)\ní™˜ìê°€ ë¬¸ì„ ì—´ê³  ë“¤ì–´ì˜¬ ë•Œë¶€í„° ì§„ë‹¨ì´ ì‹œì‘ë©ë‹ˆë‹¤. ì™œ ì´ëŸ° ì¦ìƒì´ ìƒê¸°ëŠ”ì§€ **Pathophysiology**ë¥¼ ì´í•´í•˜ì„¸ìš”.\n- **Hyperestrogenism (Estrogen ê³¼ë‹¤)**: ê°„ì´ Sex hormoneì„ ëŒ€ì‚¬í•˜ì§€ ëª»í•´ Estrogenì´ ìŒ“ì…ë‹ˆë‹¤.\n    - **Spider Angioma:** ìƒì²´(SVC distribution)ì— ì£¼ë¡œ ë°œìƒ. ëˆ„ë¥´ë©´ ì‚¬ë¼ì§.\n    - **Palmar Erythema:** ì†ë°”ë‹¥ì´ ë¶‰ì–´ì§. (Vasodilation)\n    - **Gynecomastia & Testicular Atrophy:** ë‚¨ì„± í™˜ìì˜ ì—¬ì„±í™”. ğŸ˜¢\n- **Other Signs:**\n    - **Caput Medusae:** ë°°ê¼½ ì£¼ë³€ ì •ë§¥ í™•ì¥ (Portal HTN).\n    - **Dupuytren's Contracture:** ì†ë°”ë‹¥ ê·¼ë§‰ ë¹„í›„.\n### 2. The Plumbing Problem: Portal Hypertension ğŸš°\nê°„ì´ ë²½ëŒì²˜ëŸ¼ ë”±ë”±í•´ì§€ë‹ˆ í˜ˆì•¡ì´ ê°„ì„ í†µê³¼í•˜ì§€ ëª»í•©ë‹ˆë‹¤. ì••ë ¥ì´ ë’¤ë¡œ ê±¸ë¦¬ê² ì£ ? (Back pressure).\n- **Splenomegaly:** ë¹„ì¥ì´ ì»¤ì§€ë©´ì„œ Plateletì„ íŒŒê´´í•¨ â†’ **Thrombocytopenia**.\n- **Varices:** Esophageal, Gastric varices (ì¶œí˜ˆ ìœ„í—˜!).\n- **Ascites:** ë°°ì— ë¬¼ì´ ì°¸.\n- **Drugs to Avoid**! ìœ íš¨í˜ˆë¥˜ëŸ‰ì„ ì§€í‚¬ë ¤ë©´ ì•ë¬¸ì€ ì—´ê³  ë‚˜ê°€ëŠ” ë¬¸ì€ ì¢ê²Œí•´ì•¼ë¨ (ê·¸ë˜ì„œ ê°„ê²½í™”ì—ì„œ RAASí•­ì§„)\n    - Closing the front door: NSAID\n    - Opening the exit door too wide: ACEi ARB\n## 4.2.2 Ascites & SBP (The Fluid Problem) ğŸ’§\n### 1. Diagnosis: SAAG Score (Serum-Ascites Albumin Gradient)\nìˆ˜í•™ ê³µì‹ì´ ì•„ë‹™ë‹ˆë‹¤. **Physics(ë¬¼ë¦¬)**ì…ë‹ˆë‹¤! \"Starling Forces\"ë¥¼ ìƒê°í•˜ì„¸ìš”.\n$$SAAG = Serum Albumin - Ascites Albumin$$\n- **Interpretation:** SAAGëŠ” \"í”¼ ì†ì— Albuminì´ ë¬¼ì„ ì–¼ë§ˆë‚˜ ê½‰ ì¡ê³  ìˆëŠ”ê°€(Oncotic pressure)\"ì™€ \"í˜ˆê´€ ì••ë ¥ì´ ë¬¼ì„ ì–¼ë§ˆë‚˜ ë°€ì–´ë‚´ëŠ”ê°€(Hydrostatic pressure)\"ì˜ ì‹¸ì›€ì…ë‹ˆë‹¤.\n    - **SAAG â‰¥ 1.1 (High Gradient):** **Portal Hypertension**. í˜ˆê´€ ì••ë ¥ì´ ë„ˆë¬´ ì„¸ì„œ ë¬¼(Water)ë§Œ ì‚ì ¸ë‚˜ì˜¨ ê²ë‹ˆë‹¤. (Albuminì€ í˜ˆê´€ ì•ˆì— ë‚¨ìŒ).\n        - Causes: **Cirrhosis**, Heart Failure (Right-sided), Budd-Chiari.\n    - **SAAG < 1.1 (Low Gradient):** **No** Portal Hypertension. í˜ˆê´€ì´ í—ê±°ì›Œì ¸ì„œ ë‹¨ë°±ì§ˆë„ ê°™ì´ ì¤„ì¤„ ìƒŒ ê²ë‹ˆë‹¤. (Leaky capillaries).\n        - Causes: Cancer (Peritoneal carcinomatosis), TB, Nephrotic syndrome, Pancreatitis.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-156","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 2. Treatment of Ascites\n- **1st Line:** Sodium Restriction (<2g/day).\n- **Diuretics:** **Spironolactone : Furosemide = 100 : 40 mg ratio**.\n    - ì´ ë¹„ìœ¨ì„ ìœ ì§€í•´ì•¼ **Potassium (K+) balance**ê°€ ë§ìŠµë‹ˆë‹¤ (Spironolactoneì€ K+ ì¡ê³ , FurosemideëŠ” K+ ë²„ë¦¼).\n- **Refractory Ascites:** Large Volume Paracentesis (LVP) or TIPS.\n    - [Note] LVP ì‹œ 5L ì´ìƒ ë½‘ìœ¼ë©´ ë°˜ë“œì‹œ **Albumin**ì„ ë³´ì¶©í•´ì¤˜ì•¼ í•©ë‹ˆë‹¤. (ì•ˆ ê·¸ëŸ¬ë©´ Circulatory collapse ì˜´).\n### 3. Spontaneous Bacterial Peritonitis (SBP) ğŸ¦ \në°°ì— ê³ ì¸ ë¬¼(Ascites)ì€ ì„¸ê· ì—ê²Œ ë”°ëœ»í•œ **Petri Dish**ì…ë‹ˆë‹¤. ì¥ë‚´ ì„¸ê· (E. coli, Klebsiella)ì´ ì¥ë²½ì„ ëš«ê³  ë„˜ì–´ì˜µë‹ˆë‹¤ (Translocation).\n- **Diagnosis:** Paracentesis is Mandatory!\n    - **Neutrophils (PMN) â‰¥ 250/mmÂ³** â†’ **Diagnostic!** (Culture ê²°ê³¼ ê¸°ë‹¤ë¦¬ì§€ ë§ê³  ì¹˜ë£Œ ì‹œì‘).\n- Clinical Manifestation: AMS â˜… (SBP infectionâ†’ HE), ë¯¸ì—´, tenderness, acute AKI.. ì¦ìƒì´ ì• ë§¤í•¨\n- **Treatment:**\n    1. **Antibiotics:** 3rd Gen Cephalosporin (**Ceftriaxone** or Cefotaxime).\n    2. **IV Albumin:** â˜… **CRITICAL STEP**. SBP í™˜ìì—ì„œ **Hepatorenal Syndrome**ì„ ì˜ˆë°©í•˜ê³  ìƒì¡´ìœ¨ì„ ë†’ì…ë‹ˆë‹¤. (í˜ˆê´€ ë‚´ ìœ íš¨ í˜ˆì¥ëŸ‰ì„ ìœ ì§€).\n- **Prophylaxis:** SBP ë³‘ë ¥ì´ ìˆê±°ë‚˜, Ascites proteinì´ ë„ˆë¬´ ë‚®ìœ¼ë©´(<1.5) ì˜ˆë°©ì  í•­ìƒì œ (**Fluoroquinolone**)ë¥¼ ì”ë‹ˆë‹¤.\n---\n## 4.5 Hepatorenal Syndrome (HRS) â˜ ï¸\nê°„ì´ ë§ê°€ì ¸ì„œ ì½©íŒ¥ì´ ì£½ëŠ” ë³‘ì…ë‹ˆë‹¤. **The Kidneys are Innocent bystanders!** ì½©íŒ¥ ìì²´ëŠ” ë©€ì©¡í•©ë‹ˆë‹¤.\nThey are being starved!\n- **Pathophysiology:**\n    1. Portal HTN â†’ Splanchnic Vasodilation (ì¥ ìª½ í˜ˆê´€ì´ ì—„ì²­ ëŠ˜ì–´ë‚¨).\n    2. Effective Arterial Blood Volume (EABV) ê°ì†Œ (í”¼ê°€ ì¥ ìª½ì— ë‹¤ ì ë¦¼).\n    3. KidneyëŠ” \"ì•—! í”¼ê°€ ì•ˆ ì˜¤ë„¤? ì‡¼í¬ì¸ê°€?\"ë¼ê³  ì°©ê°.\n    4. RAAS System í’€ê°€ë™ â†’ **Renal Vasoconstriction** (ì½©íŒ¥ í˜ˆê´€ì„ ê½‰ ì ê¸ˆ).\n    5. ìŠ¤ìŠ¤ë¡œ choke themselves â†’ commit suicide to save the systemic blood pressure.\n    6. ê²°êµ­ ì½©íŒ¥ìœ¼ë¡œ í”¼ê°€ ì•ˆ ê°€ì„œ **Renal Failure** ë°œìƒ.\n- **Trigger:** SBP, ê³¼ë„í•œ ì´ë‡¨ì œ ì‚¬ìš©, GI Bleeding.\n- **Diagnosis:**\n    - Cirrhosis + Cr ìƒìŠ¹.\n    - **Prerenalê³¼ ë¹„ìŠ·í•´ë³´ì´ì§€ë§Œ êµ¬ë¶„í•˜ëŠ” ë²• : Volume Challenge (Albumin)ì— ë°˜ì‘ ì—†ìŒ**.\n    - Urine Na < 10, FeNa < 1% (Pre-renal ì–‘ìƒ).\n- **Treatment: Splanchnic vasoconstrictionì„ ì¹˜ë£Œ!**\n    - Goal: Splanchnic vasoconstrictionì„ ìœ ë„í•´ì„œ í”¼ë¥¼ ì½©íŒ¥ìœ¼ë¡œ ë³´ë‚´ì•¼ í•¨.\n    - **Triple Therapy:** **Midodrine** (Systemic vasoconstrictor alpha 1 agonist) + **Octreotide** (Splanchnic vasoconstrictor) + **Albumin** (Volume expander).\n    - **Definitive Tx:** **Liver Transplant**. (ê°„ì„ ë°”ê¿”ì•¼ ì½©íŒ¥ì´ ì‚°ë‹¤).\n---\n## 4.3 Hepatic Encephalopathy (HE) ğŸ§ \nê°„ì´ í•´ë… ëª»í•œ **Ammonia (NH3)**ê°€ ë‡Œë¡œ ê°€ì„œ Neurotoxinìœ¼ë¡œ ì‘ìš©í•©ë‹ˆë‹¤.\n- **Triggers (Precipitating Factors):** ì´ê±¸ ì°¾ì•„ì„œ êµì •í•˜ëŠ” ê²Œ ì¹˜ë£Œì˜ í•µì‹¬!\n    - **Drugs:** Sedatives, Narcotics.\n    - Hypovolemia: Diarrhea, over diuresis. Decreased renal clearance of ammonia\n    - **Infection:** SBP, Pneumonia, UTI. (Catabolism ì¦ê°€).\n    - **GI Bleeding:** í”¼(Blood) = ê³ ë‹¨ë°± ì‹ì‚¬(Protein load) â†’ ì•”ëª¨ë‹ˆì•„ í­ë°œ.\n    - **Constipation:** ë³€ì´ ì¥ì— ì˜¤ë˜ ë¨¸ë¬¼ë©´ ì•”ëª¨ë‹ˆì•„ í¡ìˆ˜ ì¦ê°€.\n    - **Hypokalemia:** Kidneyì—ì„œ Ammonia ìƒì„±ì„ ì¦ê°€ì‹œí‚´. (ì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ ë¶€ë¶„! K+ê°€ ë‚®ìœ¼ë©´ ì½©íŒ¥ì´ H+ë¥¼ ì•„ë¼ë ¤ê³  NH3ë¥¼ ë” ë§ì´ ë§Œë“¦).\n    - TIPS ìˆ˜ìˆ \n- **Symptoms:** Confusion, Sleep-wake cycle reversal, **Asterixis** (Flapping tremor).\n- **Treatment:**\n    - 1st Line: **Lactulose**. (ì¥ë‚´ ì‚°ë„(pH)ë¥¼ ë‚®ì¶°ì„œ NH3(í¡ìˆ˜ë¨)ë¥¼ NH4+(ë°°ì„¤ë¨)ë¡œ ë°”ê¿ˆ + ë³€ìœ¼ë¡œ ë°°ì¶œ). \"Poop it out!\"\n    - Add-on: **Rifaximin**. (ì¥ë‚´ ì„¸ê· ì„ ì£½ì—¬ì„œ ì•”ëª¨ë‹ˆì•„ ìƒì„± ê°ì†Œ).\n---\n## 4.4 Hepatopulmonary Syndrome (HPS) ğŸ«\nê°„ê²½ë³€ í™˜ìì˜ í í˜ˆê´€ì´ ë¹„ì •ìƒì ìœ¼ë¡œ í™•ì¥(Vasodilation)ë˜ì–´ ìƒê¸°ëŠ” ì €ì‚°ì†Œì¦.\n- ë§Œì„±ì ì¸ Splanchnic vasodilation â†’ í í˜ˆê´€ë„ í™•ì¥ â†’ í í•˜ë¶€ëŠ” ê³ ì†ë„ë¡œê°€ ë„“ì–´ì ¸ì„œ ê°€ìŠ¤ êµí™˜ ì•ˆí•˜ê³  í”¼ê°€ ì‘¹ ì‘¹ ë‹¤ë‹˜\n- 100ì°¨ì„  ê³ ì†ë„ë¡œì—ì„œ ì‹œì† 200ìœ¼ë¡œ ë‹¬ë¦¬ëŠ” ìŠˆí¼ì¹´ë“¤ì´ ì£¼ìœ ì†Œ ëª»ë“¤ë¦¬ê³  ì£¼ìœ ì†Œë¥¼ ì§€ë‚˜ì¹¨.\n- **Classic Symptom:** **Platypnea** (ì¼ì–´ë‚˜ë©´ ìˆ¨ì°¸) & **Orthodeoxia** (ì¼ì–´ë‚˜ë©´ SpO2 ë–¨ì–´ì§).\n    - **Mechanism:** íì˜ ê¸°ì €ë¶€(Base) í˜ˆê´€ì´ í™•ì¥ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ì„œ ìˆìœ¼ë©´ ì¤‘ë ¥ ë•Œë¬¸ì— í”¼ê°€ ì•„ë˜ë¡œ ì ë¦¬ëŠ”ë°, í™•ì¥ëœ í˜ˆê´€ ë•Œë¬¸ì— ì‚°ì†Œ êµí™˜ ì—†ì´ ê·¸ëƒ¥ ì§€ë‚˜ê°€ ë²„ë¦¼ (**V/Q Mismatch & Shunt**).\n- **Diagnosis:** Contrast Echocardiography (Bubble study) - ë²„ë¸”ì´ íë¥¼ í†µê³¼í•´ì„œ ì¢Œì‹¬ë°©ìœ¼ë¡œ ë„˜ì–´ì˜´.\n- **Tx:** Oxygen, **Liver Transplant** (Only cure).\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-176","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"## 4.6 Budd-Chiari Syndrome ğŸš«\n**Hepatic Vein Thrombosis** (ê°„ ì •ë§¥ì´ ë§‰í˜). í”¼ê°€ ê°„ì—ì„œ ë¹ ì ¸ë‚˜ê°€ì§€ ëª»í•˜ë‹ˆ ê°„ì´ í„°ì§ˆ ë“¯ì´ ë¶“ê³  ë³µìˆ˜ê°€ ì°¹ë‹ˆë‹¤.\n- **Patient Profile:** Hypercoagulable state (ì Šì€ ì—¬ì„± + OCP, ì„ì‹ ) ë˜ëŠ” **Polycythemia Vera** (JAK2 mutation).\n- **Symptoms:** ê¸‰ì„± ë³µí†µ(RUQ pain), ê¸‰ê²©í•œ ë³µìˆ˜, ê°„ë¹„ëŒ€, í™©ë‹¬.\n- SAAG >1.1, Protein content >2.5 (ê°„ì´ ì•„ì§ fibrosisëŠ” ì•ˆì™œì„œ í”„ë¡œí‹´ì€ ìˆìŒ. CHFë‘ ê°™ì€ì–‘ìƒ)\n- **Diagnosis:**\n    - Screening: **Doppler Ultrasound** (í˜ˆë¥˜ê°€ ì—†ëŠ” ê²ƒ í™•ì¸).\n    - Gold Standard: Venography.\n- **Treatment:** Anticoagulation, Thrombolysis, TIPS, or Transplant.\n    - Underlying cause ì¹˜ë£Œ (PV)\n---\n## 4.7 Liver Abscess: Pyogenic vs. Amebic ğŸ¦  vs ğŸ›\nì´ ë‘˜ì„ êµ¬ë³„í•˜ëŠ” ê²ƒì´ ì‹œí—˜ì˜ í•µì‹¬ì…ë‹ˆë‹¤. ì¹˜ë£Œë²•ì´ ì •ë°˜ëŒ€ê±°ë“ ìš”!\n| **Feature** | **Pyogenic Abscess (Bacteria)** | **Amebic Abscess (Parasite)** |\n| --- | --- | --- |\n| **Pathogen** | E. coli, Klebsiella, Bacteroides | *Entamoeba histolytica* |\n| **Route** | Cholangitis (Biliary tree íƒ€ê³  ì˜¬ë¼ì˜´) | Fecal-oral (ì—¬í–‰ë ¥, ë©•ì‹œì½”/ì¸ë„ ë“±) |\n| **Patient** | ê³ ë ¹, ë‹¹ë‡¨, ë‹´ë„ ì§ˆí™˜ | ì Šì€ ë‚¨ì„±, ì—¬í–‰ì, ì´ë¯¼ì |\n| **Characteristics** | Multiple lesions often | Solitary, Right Lobe usually\n+bloody diarrhea |\n| **Aspirate** | Purulent (ê³ ë¦„) | **\"Anchovy Paste\"** (ë©¸ì¹˜ì “ê°ˆìƒ‰) ğŸŸ |\n| **Treatment** | **Drainage + Antibiotics** | **Metronidazole** (**Drainage ê¸ˆì§€!**) |\n**Next Step for User:**\nì´ ê°•ì˜ ë…¸íŠ¸ëŠ” ì˜¤ë””ì˜¤ì˜ í•µì‹¬ ë‚´ìš©ì„ ì™„ë²½í•˜ê²Œ ì»¤ë²„í–ˆìŠµë‹ˆë‹¤. ì´ì œ ê´€ë ¨ëœ **UWorld ë¬¸ì œ(GI/Hepatology)**ë¥¼ í’€ë©´ì„œ ì´ ê°œë…ë“¤ì„ ì ìš©í•´ë³´ì„¸ìš”. íŠ¹íˆ **SAAG ê³„ì‚°**ê³¼ **HRS ì¹˜ë£Œ í”„ë¡œí† ì½œ**ì€ ê¼­ ì•”ê¸°í•´ì•¼ í•©ë‹ˆë‹¤! í™”ì´íŒ…! ğŸ’ªğŸ‘¨â€âš•ï¸\n---\n## [5-5.6] ğŸ¥ **Biliary Tract Stones & Emergencies: The Ultimate Field Manual**\n**One Line Vibe:** ğŸš ë§ˆì¹˜ êµ°ì˜ê´€ì´ ì‘ê¸‰ì‹¤ ë‹¹ì§ ì„¤ ë•Œì²˜ëŸ¼, ì–¸ì œ ì¹¼ì„ ëŒ€ê³ (Surgery), ì–¸ì œ ê´€ì„ ëš«ê³ (Drainage), ì–¸ì œ ì§€ì¼œë´ì•¼(Observe) í•˜ëŠ”ì§€ ê²°ì •í•˜ëŠ” \"Timing & Triage\" ì‹¸ì›€ì…ë‹ˆë‹¤.\n---\n### ğŸŒ³ **Big Picture: Top-Down Classification (ASCII Tree)**\nì˜í•™ ê³µë¶€í•  ë•Œ ê°€ì¥ ì¤‘ìš”í•œ ê±´ ë‚´ê°€ ì§€ê¸ˆ ìˆ²ì˜ ì–´ë””ì— ìˆëŠ”ì§€ ì•„ëŠ” ê±°ì•¼. Biliary tract ì§ˆí™˜ì€ í¬ê²Œ **Stones(ëŒ)**ì´ëƒ ì•„ë‹ˆë©´ **Stricture/Inflammation(í˜‘ì°©/ì—¼ì¦)**ì´ëƒë¡œ ë‚˜ë‰˜ê³ , ìœ„ì¹˜ì— ë”°ë¼ ì ‘ê·¼ë²•ì´ ë‹¬ë¼ì ¸.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-196","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"Plaintext\n`BILIARY TRACT PATHOLOGY\nâ”‚\nâ”œâ”€â”€ 1. Diagnostic Framework (The Fork in the Road)\nâ”‚   â”œâ”€â”€ Lab: Elevated Alk Phos (Alkaline Phosphatase)\nâ”‚   â”‚   â”œâ”€â”€ GGT Normal â†’ Bone origin\nâ”‚   â”‚   â””â”€â”€ GGT Elevated â†’ Hepatobiliary origin (CONFIRMED)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Imaging: RUQ Ultrasound (The Workhorse)\nâ”‚       â”œâ”€â”€ Dilated Ducts â†’ Extrahepatic Obstruction (Stone, Tumor)\nâ”‚       â””â”€â”€ Normal Ducts â†’ Intrahepatic Pathology (Medical issue)\nâ”‚\nâ”œâ”€â”€ 2. Stone Disease (Gallstones)\nâ”‚   â”œâ”€â”€ Asymptomatic â†’ Do Nothing (Category 1)\nâ”‚   â”œâ”€â”€ Biliary Colic â†’ Elective Cholecystectomy (Category 2)\nâ”‚   â””â”€â”€ Complicated Disease (Category 3)\nâ”‚       â”œâ”€â”€ Cystic Duct Obstruction â†’ Acute Cholecystitis\nâ”‚       â”œâ”€â”€ Common Bile Duct (CBD) Obstruction â†’ Choledocholithiasis\nâ”‚       â””â”€â”€ CBD Infection â†’ Acute Cholangitis (EMERGENCY!)\nâ”‚\nâ”œâ”€â”€ 3. Special Critical Care Situations\nâ”‚   â”œâ”€â”€ Acalculous Cholecystitis (ICU patient, no stones)\nâ”‚   â””â”€â”€ Emphysematous Cholecystitis (Diabetic male, gas in wall)\nâ”‚\nâ””â”€â”€ 4. Chronic/Autoimmune Conditions\n    â”œâ”€â”€ PSC (Primary Sclerosing Cholangitis) â†’ Men, UC, \"Beads on string\"\n    â””â”€â”€ PBC (Primary Biliary Cholangitis) â†’ Women, Itching, AMA+`\n---\n### ğŸ§ª **1. General Evaluation & Labs**\nì—¬ê¸°ê°€ ì²« ë²ˆì§¸ í•¨ì •(Trap)ì´ì•¼. **Alk Phos**ê°€ ë–´ë‹¤ê³  ë¬´ì¡°ê±´ ê°„/ë‹´ë„ ë¬¸ì œë¼ê³  ë‹¨ì • ì§“ì§€ ë§ˆ.\n- **The Tie-Breaker:** **GGT (Gamma-glutamyl transferase)**\n    - Alk Phosê°€ ë†’ì€ë° GGTê°€ ì •ìƒì´ë‹¤? â†’ **Bone** issue (Paget's, Mets).\n    - Alk Phos + GGT ë‘˜ ë‹¤ ë†’ë‹¤? â†’ **Hepatobiliary** origin í™•ì •! ğŸ¯\n    - **Pearl:** ì•Œì½”ì˜¬ ì„­ì·¨ë§Œìœ¼ë¡œë„ GGTëŠ” ì˜¤ë¥¼ ìˆ˜ ìˆìœ¼ë‹ˆ History í™•ì¸ í•„ìˆ˜.\n- **Imaging Workhorse:** **RUQ Ultrasound**\n    - ê°€ì„±ë¹„ ìµœê³ , ë°©ì‚¬ì„  ì—†ìŒ. ë‹´ë„ê³„ì˜ **First-line test**.\n    - ì—¬ê¸°ì„œ **Duct Dilation** ìœ ë¬´ê°€ managementì˜ ê°ˆë¦¼ê¸¸(Fork in the road)ì´ ë¨.\n        - **Dilated:** ê¸¸ì´ ë§‰í˜”ë‹¤ (Mechanical Obstruction) â†’ **ERCP** ê°ì„ ë´ì•¼ í•¨.\n        - **Normal Ducts:** ê°„ ë‚´ë¶€ì˜ ë¬¸ì œë‹¤ (Intrahepatic medical issue) â†’ **Biopsy**ë‚˜ í•­ì²´ ê²€ì‚¬ ê³ ë ¤. (ë‚´ê³¼ì ì‚¬ê³ ) (ERCPí•˜ì§€ ì•ŠëŠ”ë‹¤.)\n---\n### ğŸª¨ **2. Management of Gallstones (The 3 Categories)**\nëŒì´ ìˆë‹¤ê³  ë‹¤ ê°™ì€ ëŒì´ ì•„ë‹˜! í™˜ìê°€ ì–´ë–¤ ìƒíƒœëƒì— ë”°ë¼ ëŒ€ì²˜ê°€ ì™„ì „íˆ ë‹¬ë¼ì§.\n### **Category 1: Asymptomatic Cholelithiasis (ìš°ì—°íˆ ë°œê²¬ëœ ëŒ)**\n- **Scenario:** ë”´ ê±° ê²€ì‚¬í•˜ë‹¤ê°€ ë°œê²¬ë¨. ì¦ìƒ ì—†ìŒ. í”¼ì ë¨¹ì–´ë„ ì•ˆ ì•„í””.\n- **Action:** **No Treatment (Observation).**\n    - ê±´ë“œë ¤ë´¤ì ìˆ˜ìˆ  ë¦¬ìŠ¤í¬ê°€ ì´ë“ë³´ë‹¤ í¼. ê·¸ëƒ¥ ë†”ë‘ì„¸ìš”.\n### **Category 2: Biliary Colic (ë‹´ë„ ì‚°í†µ)**\n- **Scenario:** ê¸°ë¦„ì§„ ê±°(Fatty meal) ë¨¹ê³  30ë¶„ ë’¤ì— ëª…ì¹˜ë‚˜ RUQê°€ ì¥ì–´ì§œë“¯ ì•„í””. í†µì¦ì´ **Right Scapula**ë¡œ ë»—ì¹¨ (Boas sign).\n- **Pathophysiology:** ëŒì´ ë‹´ë‚­ ì…êµ¬(Cystic duct)ë¥¼ ì ê¹ ë§‰ì•˜ë‹¤ê°€ ë‹¤ì‹œ ë–¨ì–´ì§.\n- **Action:** **Elective Laparoscopic Cholecystectomy.**\n    - ì‘ê¸‰ì€ ì•„ë‹˜. í•˜ì§€ë§Œ ë†”ë‘ë©´ ì–¸ì  ê°€ ë§‰í˜€ì„œ ë¬¸ì œ ìƒê¸°ë‹ˆê¹Œ ìŠ¤ì¼€ì¤„ ì¡ê³  ìˆ˜ìˆ .\n    - **Alternative:** ìˆ˜ìˆ  ì ˆëŒ€ ëª» í•˜ëŠ” í• ë¨¸ë‹ˆ(Grandma with 10% EF)? â†’ **Ursodeoxycholic acid** (ëŒ ë…¹ì´ëŠ” ì•½, íš¨ê³¼ëŠ” ë³„ë¡œì„).\n### **Category 3: Complicated Gallstone Disease**\nì—¬ê¸°ê°€ ì‹œí—˜ ë¬¸ì œ ë°­(Minefield)ì„ ğŸ’£.\n**A. Acute Cholecystitis (ê¸‰ì„± ë‹´ë‚­ì—¼)**\n- **Def:** ëŒì´ Cystic ductì— **ê½‰ ë¼ì–´ì„œ ì•ˆ ë¹ ì§** â†’ ì—¼ì¦ ë°œìƒ.\n- **Sxs:** 6ì‹œê°„ ì´ìƒ ì§€ì†ë˜ëŠ” í†µì¦, ì—´(Fever), Leukocytosis.\n- **Key Sign:** **Murphy's Sign** (ìˆ¨ ë“¤ì´ë§ˆì‹œê²Œ í•˜ê³  RUQ ëˆ„ë¥´ë©´ 'ì–µ!' í•˜ê³  ìˆ¨ ë©ˆì¶¤).\n- **Dx:** US (Wall thickening, pericholecystic fluid). ë§Œì•½ USê°€ ì• ë§¤í•˜ë©´? â†’ **HIDA scan** (Gold standard for diagnosis).\n- **Tx:**\n    1. NPO, IV Fluids, Antibiotics.\n    2. **Cholecystectomy within 72 hours** (ì—¼ì¦ì´ ë–¡ì§€ê¸° ì „ì— ë¹¨ë¦¬ ë–¼ëŠ” ê²Œ ë‚˜ìŒ).\n**B. Choledocholithiasis (ì´ë‹´ê´€ ê²°ì„)**\n- **Def:** ëŒì´ ë‹´ë‚­ì„ íƒˆì¶œí•´ì„œ **Common Bile Duct (CBD)**ë¥¼ ë§‰ìŒ.\n- **Lab:** Alk Phos â†‘, Direct Bilirubin â†‘ (Jaundice), LFT â†‘.\n- **Imaging:** USì—ì„œ **Dilated CBD** ë³´ì„.\n- **Tx:**\n    - **ERCP** (ë‚´ì‹œê²½ìœ¼ë¡œ ëŒ ë¨¼ì € ëºŒ) â†’ ë‚˜ì¤‘ì— **Cholecystectomy** (ì¬ë°œ ë°©ì§€).\n**C. Acute Cholangitis (ê¸‰ì„± ë‹´ê´€ì—¼) - â˜…MEDICAL EMERGENCYâ˜…**","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-216","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Def:** CBDê°€ ë§‰íŒ ìƒíƒœì—ì„œ **ê°ì—¼(Infection)**ê¹Œì§€ ë¨. ê³ ì¸ ë¬¼ì€ ì©ëŠ”ë‹¤!\n- Etiology: ascending infection due to biliary obstruction.\n- Labs: cholestatic pattern (high direct bilirubin, high ALP), anion gap metabolic acidosis (septic â†’ organ oxygenation ì•ˆë¨ â†’ lactate)\n- **Sxs:**\n    - **Charcotâ€™s Triad:** Fever + RUQ Pain + Jaundice.\n    - **Reynoldsâ€™ Pentad (bacteriaê°€ í”¼ë„ ì¹¨ë²”, decompensated):** Triad + **Hypotension (Shock)** + **Confusion**.\n- **Tx:** ì‹œê°„ ì‹¸ì›€! â³\n    1. **Resuscitate:** ìˆ˜ì•¡ ì½¸ì½¸, í˜ˆì•• ì¡ì•„.\n    2. **Antibiotics:** Broad-spectrum (e.g., Piperacillin-Tazobactam).\n    3. **Biliary Drainage (Life-saving):** **Emergent ERCP**ë¡œ ë§‰íŒ ê³³ ëš«ê³  ë†(Pus)ì„ ë¹¼ì¤˜ì•¼ í•¨.\n        1. Charcotâ€™s triadë©´ í•­ìƒì œ ì£¼ê³  1-2ì¼ í›„ì— ì•„ì¹¨ì— í•œë‹¤.\n        2. Reynoldâ€™s pentad (AMS, shock) ìˆìœ¼ë©´ ìƒˆë²½ 2ì‹œì—ë¼ë„ í•œë‹¤.\n---\n### ğŸš¨ **3. Special Critical Care Situations (The Silent Killers)**\nì¼ë°˜ì ì¸ ëŒ í™˜ìê°€ ì•„ë‹˜. ICUë‚˜ ì‘ê¸‰ì‹¤ì—ì„œ ë§ˆì£¼ì¹  ìµœì•…ì˜ ì‹œë‚˜ë¦¬ì˜¤ë“¤.\n### **â‘  Acalculous Cholecystitis (ë¬´ê²°ì„ ë‹´ë‚­ì—¼)**\n- **Who:** ICUì— ì˜¤ë˜ ëˆ„ì›ŒìˆëŠ” ì¤‘í™˜ì (Trauma, Burn, Sepsis). ë§ë„ ëª» í•˜ê³  ì¸ê³µí˜¸í¡ê¸° ë‹¬ê³  ìˆìŒ.\n- **Patho:** **Stasis & Ischemia**. ëŒì€ ì—†ëŠ”ë°, ì•ˆ ë¨¹ìœ¼ë‹ˆê¹Œ ë‹´ì¦™ì´ ì•ˆ íë¥´ê³  ì©ì–´ì„œ ë‹´ë‚­ì´ ì©ì–´ë“¤ì–´ê°.\n- **Biles are meant to move**\n- **Diagnosis:** ì„¤ëª… ì•ˆ ë˜ëŠ” Sepsis/Feverê°€ ìˆì„ ë•Œ ì˜ì‹¬í•´ì•¼ í•¨.\n- **Tx:** ì´ í™˜ìë“¤ì€ ìˆ˜ìˆ ë°© ê°€ë©´ ì£½ìŒ.\n    - **Percutaneous Cholecystostomy (PCN):** ì˜ìƒ ì˜í•™ê³¼ ë¶ˆëŸ¬ì„œ íŠœë¸Œ ê½‚ê³  ë°°ì•¡(Drain)ë§Œ ë¨¼ì € í•´ì¤Œ. ìˆ˜ìˆ ì€ ë‚˜ì¤‘ì— í™˜ì ì‚´ì•„ë‚˜ë©´ ê³ ë¯¼.\n### **â‘¡ Emphysematous Cholecystitis (ê¸°ì¢…ì„± ë‹´ë‚­ì—¼)**\n- **Who:** **Diabetic Male**. (í• ì•„ë²„ì§€ ë‹¹ë‡¨ í™˜ì).\n- **Patho:** ê°€ìŠ¤ í˜•ì„± ê· (**Clostridium**, E. coli) ê°ì—¼ â†’ ë‹´ë‚­ ë²½ì— ê³µê¸°(Air)ê°€ ë³´ì„.\n- **Imaging:** X-rayë‚˜ CTì—ì„œ ë‹´ë‚­ ë²½ì— **Air-fluid level** ë³´ì„. Air in the wall!\n- **Tx:** **Emergency Cholecystectomy.**\n    - ê¸°ë‹¤ë¦¬ë©´ í„°ì§(Perforation). í•­ìƒì œ(Zosyn) ì“°ë©´ì„œ ë°”ë¡œ ìˆ˜ìˆ ë°© ë“¤ì–´ê°€ì•¼ í•¨.\n- Cf. Pneumobilia: Biliary ductì™€ ì¥ê´€ê³¼ fistula ìƒì„± â†’ ê´€ì— ê³µê¸°ê°€ ë“¤ì–´ê°.\n---\n### ğŸ§¬ **4. Autoimmune: PSC vs. PBC (The Classic Showdown)**\nì´ê±° ì¡±ë³´(USMLE favorite) ë¹„êµ ë¬¸ì œì„. ë¬´ì¡°ê±´ ë‚˜ì˜´.\n| **Feature** | **PSC (Primary Sclerosing Cholangitis)** | **PBC (Primary Biliary Cholangitis)** |\n| --- | --- | --- |\n| **Demographics** | **Men** (30-50s) | **Women** (Middle-aged) |\n| **Association** | **Ulcerative Colitis (UC)** (90%ê°€ UC ë™ë°˜) | Autoimmune disease (Sjogren's, Hashimoto's) |\n| **Pathology** | Intra & Extrahepatic ducts ë‹¤ ì¹¨ë²” | Intrahepatic ducts (ì‘ì€ ë‹´ê´€)ë§Œ ì¹¨ë²” |\n| **Imaging (ERCP/MRCP)** | **\"Beads on a String\"** (ì¢ì•„ì¡Œë‹¤ ë„“ì–´ì¡Œë‹¤ í•¨) | Normal extrahepatic ducts |\n| **Antibody** | p-ANCA (+) (not specific) | **Anti-Mitochondrial Antibody (AMA) (+)** |\n| **Symptoms** | Jaundice, Pruritus, Fatigue | **Severe Pruritus (ê°€ë ¤ì›€)**, Xanthelasma (ëˆˆê°€ ì§€ë°©) |\n| **Risk** | **Cholangiocarcinoma**, Colon Cancer | Cirrhosis |\n| **Treatment** | Transplant (ìœ ì¼í•œ ì™„ì¹˜), ERCP (ì¦ìƒ ì™„í™”) | **Ursodeoxycholic Acid (Ursodiol)** |\n---\n### ğŸ¤• **5. Post-Cholecystectomy Syndrome (ìˆ˜ìˆ í–ˆëŠ”ë° ì™œ ì•„íŒŒìš”?)**\n- **Scenario:** ë‹´ë‚­ ì ˆì œìˆ  ë°›ì•˜ëŠ”ë° ëª‡ ì£¼/ëª‡ ë‹¬ ë’¤ì— ë˜‘ê°™ì´ ì•„í””.\n- **Causes:**\n    1. **Retained Stone:** ìˆ˜ìˆ í•˜ë‹¤ê°€ CBDì— ëŒ í•˜ë‚˜ í˜ë¦¬ê³  ì˜´.\n    2. **Sphincter of Oddi Dysfunction (SOD):** ê´„ì•½ê·¼ì´ ê³¼í•˜ê²Œ ìˆ˜ì¶•í•¨.\n    note: morphinerê³¼ ê°™ì€ ì§„í†µì œê°€ ì˜¤íˆë ¤ ì˜¤ë””ê·¼ ìˆ˜ì¶•ì„ ì¼ìœ¼í‚´.\n    3. **Non-biliary:** ìœ„ì—¼, ê¶¤ì–‘ ë“± ë‹¤ë¥¸ ì›ì¸.\n- **Workup:** US/CT ë¨¼ì € â†’ Dilated duct ìˆìœ¼ë©´ **ERCP**.\n---","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-236","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\nì˜¤ë””ì˜¤ì—ì„œ ê°•ì¡°í•œ í•µì‹¬ ì‹œë‚˜ë¦¬ì˜¤ ì •ë¦¬í‘œ!\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis (ì§„ë‹¨)** | **Key Action / Trap (í•µì‹¬)** |\n| --- | --- | --- |\n| **Fatty meal** í›„ 30ë¶„ ë’¤ í†µì¦, 6ì‹œê°„ ë‚´ ì†Œì‹¤ | **Biliary Colic** | **Elective Lap Chole**. (ì‘ê¸‰ ì•„ë‹˜) |\n| RUQ pain, **Fever**, **Murphy's sign (+)** | **Acute Cholecystitis** | **HIDA scan** if US equivocal. **Surgery within 72h**. |\n| **Jaundice**, Alk Phos â†‘, Dilated CBD on US | **Choledocholithiasis** | **ERCP** first (Remove stone) â†’ then Cholecystectomy. |\n| **Fever + Jaundice + RUQ Pain** (Charcot) | **Acute Cholangitis** | **Emergent ERCP** (Drainage) + IV Abx + Fluids. |\n| **ICU Patient**, Sepsis, No stones on US | **Acalculous Cholecystitis** | **Cholecystostomy Tube** (Do NOT operate yet). |\n| **Diabetic Male**, Air in GB wall | **Emphysematous Cholecystitis** | **Emergency Surgery** (High risk of perforation). |\n| **Male with UC**, Jaundice, Itching | **PSC** | Screen for **Cholangiocarcinoma**. Look for \"Beads on string\". |\n| **Middle-aged Woman**, Itching, Fatigue | **PBC** | Check **Anti-Mitochondrial Ab (AMA)**. Tx: Ursodiol. |\n---\n**[Next Step for User]**\nWould you like me to generate specific Anki card content for the **\"PSC vs PBC\"** differentiation or the **\"Management Hierarchy of Cholangitis\"** to help you lock this into your long-term memory?\n---\n# ğŸ¥ USMLE Step 2 CK: The Angry Pancreas & The Silent Spleen","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-252","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","recap","diagnosis","treatment","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"## ğŸ“‹ Overview: A Tale of Two Organs\nì—¬ê¸° ë‘ ê°€ì§€ ìƒë°˜ëœ ì„±ê²©ì„ ê°€ì§„ ì¥ê¸°ê°€ ìˆìŠµë‹ˆë‹¤. USMLEëŠ” ì´ë“¤ì˜ \"Personality\"ë¥¼ ì´í•´í•˜ëŠ” ê²ƒì„ ì¢‹ì•„í•©ë‹ˆë‹¤.\n- **The Angry Pancreas ğŸ˜¡:** Retroperitoneum ê¹Šìˆ™ì´ ìˆ¨ì–´ìˆëŠ” \"ì„±ë‚œ ì¥ê¸°\". í•œë²ˆ í™”ë‚˜ë©´(Inflammation) ì˜¨ëª¸ì— systemic chaosë¥¼ ì¼ìœ¼í‚µë‹ˆë‹¤. ë‹¤ë£¨ê¸°ê°€ ë§¤ìš° ê¹Œë‹¤ë¡­ìŠµë‹ˆë‹¤.\n- **The Silent Spleen ğŸ¤«:** ì¡°ìš©í•œ í¬ìƒì(Silent victim). Systemic debrisë¥¼ ê±¸ëŸ¬ì£¼ëŠ” í•„í„° ì—­í• ì„ í•˜ë‹¤ê°€, ê²°êµ­ì—” ì¡°ìš©íˆ ì°¢ì–´ì§€ê±°ë‚˜(Rupture) ë†ì–‘(Abscess)ì„ ë§Œë“­ë‹ˆë‹¤.\n---\n## 6.0 Pancreas Overview & Acute Etiologies\n### 1. Clinical Presentation: The \"Boring\" Pain\ní™˜ìê°€ ë°°ë¥¼ ì›€ì¼œì¥ê³  ë“¤ì–´ì˜µë‹ˆë‹¤. ë‹¨ìˆœí•œ ë°°íƒˆ(IBS)ì´ ì•„ë‹™ë‹ˆë‹¤.\n- **Symptom:** Acute, Severe Epigastric Pain radiating to the **Back**.\n- **Anatomy:** PancreasëŠ” **Retroperitoneal organ**ì…ë‹ˆë‹¤. ì²™ì¶”(Spine)ì™€ ëŒ€ë™ë§¥(Aorta) ë°”ë¡œ ì•ì— ë”± ë¶™ì–´ ìˆì£ . ê·¸ë˜ì„œ ì—¼ì¦ì´ ìƒê¸°ë©´ ë“± ë’¤ì˜ Somatic nerveë¥¼ ìê·¹í•´ì„œ í†µì¦ì´ ë“± ë’¤ë¡œ ëš«ê³  ë‚˜ê°€ëŠ” ë“¯í•œ(**Boring through to the back**) ì–‘ìƒì„ ë³´ì…ë‹ˆë‹¤.\n### 2. Diagnosis: Rule of 2 out of 3\nì§„ë‹¨ì„ ìœ„í•´ ë‹¤ìŒ 3ê°€ì§€ ì¤‘ **2ê°€ì§€**ê°€ í•„ìš”í•©ë‹ˆë‹¤. (USMLEëŠ” ë¶ˆí•„ìš”í•œ í…ŒìŠ¤íŒ…ì„ ì‹«ì–´í•©ë‹ˆë‹¤!)\n1. **Clinical Presentation:** ì „í˜•ì ì¸ Epigastric pain radiating to the back.\n2. **Biochemical Evidence:** Amylase or **Lipase** > 3x Upper limit of normal.\n3. **Imaging:** CT, MRI, or Ultrasound evidence of pancreatitis.\n    1. gallstone pancreatitis ì˜ì‹¬ë ë•ŒëŠ” sono ì°ìŒ\n    2. sonoëŠ” ductë¥¼ ë³´ë©´ì„œ stoneìˆëŠ”ì§€ í‰ê°€í• ë•ŒëŠ” ì¢‹ì§€ë§Œ, ì·Œì¥ ê·¸ ìì²´ëŠ” ì˜ ëª»ë´„ (ì·Œì¥ì€ í›„ë³µë§‰ ì¥ê¸°)\n    ë”°ë¼ì„œ ì·Œì¥ì´ ì©ì—ˆëŠ”ì§€ ë“±, ì·Œì¥ì„ ì§ì ‘ ë³´ë ¤ë©´ CTë¥¼ ì°ëŠ” ê²ƒì´ ì¢‹ìŒ.\n    ë¬¼ë¡ , ì•„ë˜ tipì²˜ëŸ¼ ë³‘ ì´ˆë°˜ì— ì§„ë‹¨ìš©ìœ¼ë¡œ CTë¥¼ ì´¬ì˜í•  í•„ìš”ëŠ” ì—†ìŒ.\n### 3. Etiologies: \"GET SMASHED\" ğŸºğŸª¨\nì›ì¸ì€ ë§ì§€ë§Œ **Gallstones**ì™€ **Alcohol**ì´ 80%ë¥¼ ì°¨ì§€í•©ë‹ˆë‹¤.\n| **Etiology** | **Clue / Specifics** |\n| --- | --- |\n| **G**allstones (40%) | **ALT > 150 U/L** (PPV 95%). ë‹´ì„ì´ ë‚´ë ¤ì˜¤ë‹¤ê°€ ê°„ì„¸í¬ë¥¼ ìê·¹í•´ì„œ ALTê°€ íŒ íŠ‘ë‹ˆë‹¤. |\n| **E**thanol (40%) | History of heavy drinking. Macrocytosis (MCV > 100). |\n| **T**rauma | **Handlebar Injury** ğŸš² (ì•„ì´ë“¤ì´ ìì „ê±° ì†ì¡ì´ì— ëª…ì¹˜ë¥¼ ì°§ìŒ). ì²™ì¶”ì™€ ì†ì¡ì´ ì‚¬ì´ì—ì„œ Pancreasê°€ ìœ¼ê¹¨ì§. |\n| **S**teroids | ë“œë¬¼ì§€ë§Œ ê°€ëŠ¥. |\n| **M**umps | Viral cause. |\n| **A**utoimmune | IgG4 related disease. |\n| **S**corpion sting | ì‹œí—˜ìš© í¬ê·€ ì¼€ì´ìŠ¤. |\n| **H**ypertriglyceridemia | **TG > 1,000 mg/dL**. í”¼ë¥¼ ë½‘ìœ¼ë©´ ë”¸ê¸° ì‰ì´í¬(Strawberry milkshake)ì²˜ëŸ¼ ë³´ì…ë‹ˆë‹¤. |\n| **H**ypercalcemia | Calciumì´ íš¨ì†Œë¥¼ ì¡°ê¸° í™œì„±í™”(Premature activation) ì‹œí‚´ â†’ ê´€ì„ ë§‰ìŒ â†’ ì·Œì¥ì—¼\nì·Œì¥ì—¼ â†’ fat necrosis â†’ sponification â†’ calcium ì†Œëª¨ â†’ hypocalcemia ìœ ë°œí•¨. |\n| **E**RCP (Iatrogenic) | ì‹œìˆ  í›„ 5%ì—ì„œ ë°œìƒ. Contrast dyeë‚˜ Papilla manipulation ë•Œë¬¸. |\n| **D**rugs | **Diuretics (Thiazide/Furosemide)**, Valproic acid, Didanosine, Pentamidine, Azathioprine/6-MP. |\n---\n## 6.1 Severe Acute Pancreatitis\n### 1. Definition & Pathophysiology\në‹¨ìˆœí•œ ì—¼ì¦ì´ ì•„ë‹ˆë¼ **Organ Failure**ê°€ 48ì‹œê°„ ì´ìƒ ì§€ì†ë˜ëŠ” ìƒíƒœì…ë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-262","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Mechanism:** \"Cytokine Storm\" ğŸŒªï¸. ì·Œì¥ì´ ìì‹ ì„ ì†Œí™”ì‹œí‚¤ë©°(Autodigestion) ì—¼ì¦ ë§¤ê°œë¬¼ì§ˆ(TNF-alpha, Interleukins)ì„ ì „ì‹ ìœ¼ë¡œ ë¿Œë¦½ë‹ˆë‹¤.\n- **Result:** ì „ì‹  í˜ˆê´€ì´ í™•ì¥(Vasodilation)ë˜ê³  **í˜ˆê´€ íˆ¬ê³¼ì„±ì´ ì¦ê°€**í•˜ì—¬ í˜ˆì¥ì´ ì¡°ì§ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°‘ë‹ˆë‹¤(**Third Spacing**). ê²°êµ­ **Hypovolemic Shock**ê³¼ ìœ ì‚¬í•œ ìƒíƒœê°€ ë©ë‹ˆë‹¤.\n### 2. Predictors of Severity (Who needs ICU?)\në‹¤ìŒ ì§€í‘œë“¤ì´ ë³´ì´ë©´ ê¸´ì¥í•´ì•¼ í•©ë‹ˆë‹¤.\n- **Patient Factors:** Age > 55, **Obesity (BMI > 30)** â˜… (ì§€ë°©ì„¸í¬ ê´´ì‚¬ëŠ” ë…ì„±ì´ ê°•í•¨).\n- **Labs:**\n    - **HCT > 44%**: íƒˆìˆ˜(Hemoconcentration)ê°€ ì‹¬í•˜ë‹¤ëŠ” ì¦ê±°. í˜ˆê´€ì—ì„œ ë¬¼ì´ ë‹¤ ë¹ ì ¸ë‚˜ê°”ë‹¤ëŠ” ëœ».\n    - **BUN > 20 mg/dL (Rising BUN): ê°€ì¥ ë¬´ì„œìš´ ì‚¬ì¸ ğŸ’€. ìˆ˜ì•¡ì„ ì¤¬ëŠ”ë°ë„ BUNì´ ì˜¤ë¥¸ë‹¤ë©´ ì‚¬ë§ë¥ ì´ ê¸‰ì¦í•©ë‹ˆë‹¤.**\n    - **CRP > 150**: ì‹¬í•œ ì—¼ì¦.\n- **Physical Exam:**\n    - **Cullen's Sign:** ë°°ê¼½ ì£¼ìœ„ ë© (Periumbilical ecchymosis).\n    - **Grey Turner's Sign:** ì˜†êµ¬ë¦¬ ë© (Flank ecchymosis).\n    - *Note: ì´ ì‚¬ì¸ë“¤ì€ í›„ë³µë§‰ ì¶œí˜ˆì„ ì˜ë¯¸í•˜ë©°, ì˜ˆí›„ê°€ ë§¤ìš° ë‚˜ì©ë‹ˆë‹¤(Grim prognosis).*\n### 3. Management: The 3 Pillars ğŸ›ï¸\n1. **Fluids (Aggressive Hydration) ğŸ’§:** ê°€ì¥ ì¤‘ìš”í•©ë‹ˆë‹¤! **Lactated Ringer's (LR)**ê°€ Normal Salineë³´ë‹¤ ì„ í˜¸ë©ë‹ˆë‹¤ (ì‚°ì¦ ì˜ˆë°© ë° í•­ì—¼ì¦ íš¨ê³¼).\n2. **Analgesia ğŸ’Š:** ì•„í”ˆ ê±´ ì°¸ê²Œ í•˜ì§€ ë§ˆì„¸ìš”. **Opioids** (Fentanyl, Hydromorphone) ì‚¬ìš© ê°€ëŠ¥í•©ë‹ˆë‹¤. (ê³¼ê±°ì˜ 'Morphineì´ Sphincter of Oddië¥¼ ìˆ˜ì¶•ì‹œí‚¨ë‹¤'ëŠ” ì´ë¡ ì€ ì„ìƒì ìœ¼ë¡œ ë¬´ì‹œë©ë‹ˆë‹¤).\n3. **Nutrition ğŸ:** **Enteral Nutrition (Early feeding)**ì´ TPN(ì •ë§¥ ì˜ì–‘)ë³´ë‹¤ ì¢‹ìŠµë‹ˆë‹¤. ì¥ ì ë§‰ ì¥ë²½(Gut mucosal barrier)ì„ ìœ ì§€í•´ì„œ ë°•í…Œë¦¬ì•„ ì´ë™(Translocation)ì„ ë§‰ì•„ì•¼ í•©ë‹ˆë‹¤.\n### 4. Controversies & Pitfalls ğŸš«\n- **Antibiotics:** **Do NOT give prophylactic antibiotics.** ì—´ì´ ë‚˜ë„ ì´ˆë°˜ì—” ì—¼ì¦ ë•Œë¬¸ì…ë‹ˆë‹¤.\n    - **When to give Abx?** CTì—ì„œ ê¸°í¬(Gas)ê°€ ë³´ì´ê±°ë‚˜, ìƒê²€(Biopsy)ì—ì„œ ê°ì—¼ì´ í™•ì¸ëœ **Infected Necrosis**ì¼ ë•Œë§Œ Carbapenem ë“±ì„ ì”ë‹ˆë‹¤.\n- **Timing of CT:** ì…ì› ì´ˆê¸°ì—ëŠ” ë„ì›€ ì•ˆ ë¨. 48-72ì‹œê°„ í›„ì—ë„ ìƒíƒœê°€ ì•…í™”ë˜ê±°ë‚˜ í•©ë³‘ì¦(Necrosis, Abscess)ì´ ì˜ì‹¬ë  ë•Œ ì°ìŠµë‹ˆë‹¤.\n- **Gallstone Pancreatitis:**\n    - Mild: ì´ë²ˆ ì…ì› ê¸°ê°„ ë‚´ì— **Cholecystectomy** (ì§‘ì— ë³´ë‚´ë©´ ì¬ë°œë¥  ë†’ìŒ).\n    - Severe: ì—¼ì¦ì´ ê°€ë¼ì•‰ì„ ë•Œê¹Œì§€ ê¸°ë‹¤ë ¸ë‹¤ê°€ ìˆ˜ìˆ  (Interval cholecystectomy).\n    - gallstone pancreatitisì˜ ê²½ìš°ì—ëŠ” routine ECRP í•˜ì§€ì•ŠìŒ.\n    unless, persisted obstruction/dilation, concurrent cholangitis\n---\n## 6.2 & 6.3 Pancreatic Complications (Cysts)\n### 1. Pancreatic Pseudocyst (ê°€ì„±ë‚­ì¢…)\n- **Definition:** ì·Œì¥ íš¨ì†Œê°€ í˜ëŸ¬ë‚˜ì™€ ì„¬ìœ í™”ëœ ë²½(Fibrous tissue)ì— ê°‡íŒ ê²ƒ. **Epithelial liningì´ ì—†ìŠµë‹ˆë‹¤** (ê·¸ë˜ì„œ \"Pseudo\").\n- **Timing:** ê¸‰ì„± ì·Œì¥ì—¼ ì•“ê³  **4ì£¼ ì´í›„**ì— ë°œìƒ.\n- **Diagnosis:** CT Scan.\n- **Management:**\n    - **Asymptomatic / Small:** **Observation**. (ëŒ€ë¶€ë¶„ ì €ì ˆë¡œ ì‚¬ë¼ì§).\n    - **Symptomatic (Pain, Early satiety) / Infected / Growing:** **Drainage**. (ë‚´ì‹œê²½ì  Cystogastrostomyê°€ ì„ í˜¸ë¨).\n### 2. Pancreatic Cysts (Neoplasms)\nìš°ì—°íˆ ë°œê²¬ë˜ëŠ” ê²½ìš°ê°€ ë§ìŠµë‹ˆë‹¤ (Incidentaloma).\n- **Serous Cystadenoma:** ì–‘ì„±(Benign). ë²Œì§‘ ëª¨ì–‘(Honeycomb). ê´€ì°°.\n- **Mucinous Cystadenoma:** **Pre-malignant** (ì•”ì´ ë  ìˆ˜ ìˆìŒ). ì—¬ì„±ì—ì„œ í˜¸ë°œ. ê¼¬ë¦¬(Tail) ìª½. ìˆ˜ìˆ ì  ì ˆì œ ê³ ë ¤.\n- **IPMN (Intraductal Papillary Mucinous Neoplasm):** ì·Œê´€ê³¼ ì—°ê²°ë¨. ì•…ì„± ê°€ëŠ¥ì„± ìˆìŒ.\n- **Next Best Step for Suspicious Cysts:** **EUS (Endoscopic Ultrasound) + Biopsy (FNA)**. (í¬ê¸° > 3cm, Solid component, Pancreatic duct í™•ì¥ ì‹œ).\n---\n## 6.4 Chronic Pancreatitis\n### 1. Concept: \"Burned Out Gland\" ğŸ”¥â¡ï¸ğŸŒ‘\nê¸‰ì„± ì—¼ì¦ì´ ë°˜ë³µë˜ì–´ ì·Œì¥ì´ ëŒì²˜ëŸ¼ êµ³ê³ (Fibrosis, Calcification) ê¸°ëŠ¥ì„ ìƒì‹¤í•œ ìƒíƒœì…ë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-282","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"- **Etiology:** **Alcohol** (ì„±ì¸), **Cystic Fibrosis** (ì†Œì•„).\n- **Pathophysiology:** ë°¥ë¨¹ìœ¼ë©´ CCKê°€ ë‚˜ì˜¤ê³  CCKê°€ ì·Œì¥ ìê·¹í•˜ê³  ì·Œì¥ì—ì„œ íš¨ì†Œ ë‚´ë³´ëƒ„. ê·¼ë° ì·Œì¥ì—¼ì—ì„œ, íš¨ì†Œê°€ ì‹­ì´ì§€ì¥ìœ¼ë¡œ ì•ˆ ë‚˜ì˜¤ë‹ˆ, CCK(Cholecystokinin) ë¶„ë¹„ë¥¼ ì–µì œí•˜ëŠ” Negative feedbackì´ ê¹¨ì§‘ë‹ˆë‹¤. CCKê°€ ê³„ì† ë‚˜ì™€ ì·Œì¥ì„ ì¥ì–´ì§œë‹ˆ ì•„í”•ë‹ˆë‹¤.\n### 2. Clinical Triad\n1. **Chronic Pain:** ì‹í›„ ì•…í™”.\n2. **Exocrine Failure:** **Steatorrhea** (ì§€ë°©ë³€ - ë³€ê¸° ë¬¼ì— ê¸°ë¦„ ë‘¥ë‘¥, ëƒ„ìƒˆ ê³ ì•½í•¨). ì†Œí™”íš¨ì†Œ(Lipase) ë¶€ì¡±.\n3. **Endocrine Failure:** **Diabetes** (Type 3c). ì¸ìŠë¦° ë¶„ë¹„ ì„¸í¬ íŒŒê´´.\n### 3. Diagnosis & Management\n- **Diagnosis:** Amylase/LipaseëŠ” **ì •ìƒ**ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤ (ë§Œë“¤ ì„¸í¬ê°€ ë‹¤ ì£½ì–´ì„œ). **CT**ì—ì„œ ì·Œì¥ ì„íšŒí™”(Calcifications) í™•ì¸.\n- **Management:**\n    - **Lifestyle:** ê¸ˆì£¼(Stop Alcohol), ê¸ˆì—°(Stop Smoking). ì†ŒëŸ‰ì˜ ì €ì§€ë°© ì‹ì‚¬(Small frequent low-fat meals).\n    - **Enzyme Replacement:** **Lipase/Amylase/Protease supplements**. (CCK ë¶„ë¹„ë¥¼ ì¤„ì—¬ í†µì¦ë„ ì™„í™”ì‹œí‚´).\n    - **Diabetes:** Insulin í•„ìš”.\n- **Complication:**\n    - ì·Œì¥ì•”\n    - **Splenic Vein Thrombosis:** ì·Œì¥ ë°”ë¡œ ë’¤ì˜ ë¹„ì¥ì •ë§¥(Splenic vein)ì´ ì—¼ì¦ìœ¼ë¡œ ë§‰í˜. -> ë¹„ì¥ì´ ì»¤ì§€ê³ (Splenomegaly) -> **Gastric Varices** (ìœ„ ì •ë§¥ë¥˜)ë§Œ ìƒê¹€ (Esophageal varices ì—†ìŒ). ì¹˜ë£ŒëŠ” **Splenectomy**.\n---\n## 7.0 The Spleen\n### 1. Splenic Abscess ğŸ¦ \n- **Scenario:** ë°œì—´, ë°±í˜ˆêµ¬ ì¦ê°€, **LUQ Pain**.\n- **Cause:** **Infective Endocarditis** (ì‹¬ì¥ì˜ Septic emboliê°€ ë¹„ì¥ìœ¼ë¡œ ë‚ ì•„ê°).\n- **Management:** í•­ìƒì œë§Œìœ¼ë¡œ ì¹¨íˆ¬ê°€ ì–´ë ¤ì›€. **Splenectomy** + Antibioticsê°€ ë‹µ.\n### 2. Splenic Rupture ğŸ’¥\n- **Traumatic:** êµí†µì‚¬ê³ (MVA), ê°ˆë¹„ë¼ˆ ê³¨ì ˆ ë“±.\n- **Atraumatic:** **Epstein-Barr Virus (Infectious Mononucleosis)**. ë¹„ì¥ì´ ë¹„ëŒ€í•´ì ¸ì„œ(Splenomegaly) ì‚´ì§ë§Œ ë¶€ë”ªí˜€ë„ í„°ì§.\n- **Kehr's Sign:** **Left Shoulder Pain**. í„°ì§„ ë¹„ì¥ì˜ í”¼ê°€ íš¡ê²©ë§‰(Diaphragm)ì„ ìê·¹ -> Phrenic nerve (C3,4,5) -> ì–´ê¹¨ í†µì¦.\n### 3. Management of Splenic Trauma\n- **Hemodynamically Unstable:** ì‘ê¸‰ ìˆ˜ìˆ  (**Exploratory Laparotomy / Splenectomy**).\n- **Hemodynamically Stable:** **CT Scan** with contrast. -> ë“±ê¸‰ì— ë”°ë¼ Angiographic embolization ë˜ëŠ” Observation.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-302","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## ğŸ”¥ Rapid Fire Recap (High Yield Summary)\n1. **Epigastric pain radiating to back + Lipase > 3x** â†’ **Acute Pancreatitis** â†’ **Next Step:** Fluids (LR), Pain control, NPO. (Do NOT order CT first).\n2. **Acute Pancreatitis + ALT > 150** â†’ **Gallstone Pancreatitis** â†’ **Next Step:** RUQ Ultrasound.\n3. **Pancreatitis patient + Fever/Hypotension after 10 days + CT shows gas** â†’ **Infected Necrosis** â†’ **Next Step:** Antibiotics (Carbapenem) + Step-up drainage.\n4. **4 weeks after Pancreatitis + Early Satiety + Abdominal Mass** â†’ **Pancreatic Pseudocyst** â†’ **Next Step:** Symptomatic? Drainage (Cystogastrostomy). Asymptomatic? Observation.\n5. **Chronic Pancreatitis + Isolated Gastric Varices** â†’ **Splenic Vein Thrombosis** â†’ **Tx:** Splenectomy.\n6. **Sore throat (Mono) + Sudden LUQ pain/Shoulder pain** â†’ **Splenic Rupture** â†’ **Next Step:** Stable? CT. Unstable? OR.\n---\n# ğŸ¥ USMLE Step 2 CK: GI Deep Dive (Small Intestine)\n**Topic:** Malabsorption, IBS, IBD, Celiac, SIBO\nì•ˆë…•í•˜ì„¸ìš” ì„ ìƒë‹˜! USMLE Step 2 CK ì¤€ë¹„ë¥¼ ìœ„í•œ GI íŒŒíŠ¸ Deep Diveì…ë‹ˆë‹¤.\nì˜¤ëŠ˜ì˜ ì£¼ì œëŠ” ì†Œì¥(Small Intestine) íŒŒíŠ¸ì…ë‹ˆë‹¤. ì¦ìƒì€ ë¹„ìŠ·í•´ ë³´ì´ì§€ë§Œ(ì„¤ì‚¬, ë³µí†µ, bloating), ê´€ë¦¬ëŠ” ì²œì§€ì°¨ì´ì¸ ì§ˆí™˜ë“¤ì„ í™•ì‹¤í•˜ê²Œ êµ¬ë¶„í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\në¨¼ì € ì „ì²´ì ì¸ ê·¸ë¦¼ì„ **Big Picture**ë¡œ ì¡ê³  ë“¤ì–´ê°€ê² ìŠµë‹ˆë‹¤.","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-317","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","recap","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"## ğŸŒ³ Big Picture: The \"Bloating & Diarrhea\" Differential\nì´ íŒŒíŠ¸ì˜ í•µì‹¬ì€ **\"ë°° ì•„í”„ê³  ì„¤ì‚¬í•˜ëŠ”ë°, ë„ëŒ€ì²´ ì›ì¸ì´ ë­ëƒ?\"**ë¥¼ ê°ë³„í•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\nPlaintext\n`GI Symptoms (Pain, Diarrhea, Bloating)\nâ”‚\nâ”œâ”€â”€ Systemic Signs? (Weight loss, Blood, Anemia, Nocturnal Sx)\nâ”‚   â”œâ”€â”€ YES (Alarm Features) ğŸš¨\nâ”‚   â”‚   â”œâ”€â”€ Inflammation visible?\nâ”‚   â”‚   â”‚   â”œâ”€â”€ YES â†’ IBD (Crohn's / UC) [Sec 8.4]\nâ”‚   â”‚   â”‚   â””â”€â”€ NO â†’ Malignancy, Celiac, etc.\nâ”‚   â”‚   â””â”€â”€ Malabsorption signs? (Steatorrhea, Fat soluble vit def)\nâ”‚   â”‚       â”œâ”€â”€ Anatomy/Motility issue? â†’ SIBO [Sec 8.6]\nâ”‚   â”‚       â”œâ”€â”€ Gluten trigger? â†’ Celiac Disease [Sec 8.5]\nâ”‚   â”‚       â””â”€â”€ Bile issue? â†’ Malabsorption/Cholestasis [Sec 8.1]\nâ”‚   â”‚\nâ”‚   â””â”€â”€ NO (Functional)\nâ”‚       â””â”€â”€ Rome IV Criteria met? â†’ IBS (Irritable Bowel Syndrome) [Sec 8.3]`\n---\n## 1. Malabsorption (í¡ìˆ˜ì¥ì• ) [Sec 8.1]\n**Concept:** ë‹¨ìˆœíˆ \"ëª» ë¨¹ì–´ì„œ ë§ˆë¥¸ ê²ƒ\"ì´ ì•„ë‹ˆë¼, ìš°ë¦¬ ëª¸ì˜ ì—°ë£Œ íƒ±í¬ì— êµ¬ë©ì´ ë‚œ ìƒíƒœì…ë‹ˆë‹¤.\n### ğŸ”‘ Key Pathophysiology: The Liver-Bone Connection\nStep 2ì—ì„œ ì •ë§ ì¢‹ì•„í•˜ëŠ” ì—°ê²°ê³ ë¦¬ì…ë‹ˆë‹¤.\n- **Cholestasis (ë‹´ì¦™ ì •ì²´)** â†’ Bile acidê°€ ì‹­ì´ì§€ì¥ìœ¼ë¡œ ëª» ë‚˜ê°.\n- **No Bile** â†’ ì§€ë°©(Fat)ì„ ìœ í™”(Emulsify)ì‹œí‚¤ì§€ ëª»í•¨.\n- **Steatorrhea (ì§€ë°©ë³€)** ë°œìƒ (Greasy, foul-smelling, floating stool).\n- **Fat Soluble Vitamin (A, D, E, K) í¡ìˆ˜ ë¶ˆê°€.**\n- **â˜… Vitamin D ê²°í•** â†’ Calcium í¡ìˆ˜ ì €í•˜ â†’ **Osteoporosis / Osteomalacia (ê³¨ë‹¤ê³µì¦/ê³¨ì—°í™”ì¦)**.\n## 2. Irritable Bowel Syndrome (IBS, ê³¼ë¯¼ì„± ëŒ€ì¥ ì¦í›„êµ°) [Sec 8.3]\n**Vibe:** ê²€ì‚¬ ìƒ ì´ìƒì€ ì—†ëŠ”ë° í™˜ìëŠ” ë¯¸ì¹˜ë„ë¡ ë¶ˆí¸í•œ ìƒíƒœ. í•˜ì§€ë§Œ \"ê¾€ë³‘\" ì·¨ê¸‰í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤! ë‡Œ-ì¥ ì¶•(Gut-Brain Axis)ì˜ ë¬¸ì œì…ë‹ˆë‹¤.\n### ğŸ›‘ Diagnosis: Rome IV Criteria (í•„ìˆ˜ ì•”ê¸°!)\nIBSëŠ” ë” ì´ìƒ \"Diagnosis of exclusion(ë°°ì œ ì§„ë‹¨)\"ì´ ì•„ë‹™ë‹ˆë‹¤. **Positive Diagnosis**ì…ë‹ˆë‹¤.\n- **Recurrent Abdominal Pain:** ìµœì†Œ **1ì£¼ì¼ì— 1ì¼ ì´ìƒ**, ì§€ë‚œ 3ê°œì›” ë™ì•ˆ.\n- **Associated with 2+ of the following:**\n    1. **Defecation:** ë°°ë³€ê³¼ ì—°ê´€ë¨ (ì‹¸ê³  ë‚˜ë©´ í¸í•´ì§€ê±°ë‚˜ ë” ì•„í”„ê±°ë‚˜).\n    2. **Frequency:** ë°°ë³€ íšŸìˆ˜ì˜ ë³€í™”.\n    3. **Form:** ëŒ€ë³€ í˜•íƒœì˜ ë³€í™” (ë¬¼ë˜¥ vs ì—¼ì†Œë˜¥).\n- ë°‘ì— í‘œì—ìˆëŠ” work upì„ í•˜ê³  ì„ìƒì  ì§„ë‹¨ì„ ë‚´ë¦¬ëŠ”ê²ƒì„ â˜…\n### ğŸš© Red Flags (Alarm Features) - IBSê°€ **ì•„ë‹Œ** ì‹ í˜¸\nì´ëŸ° ì¦ìƒì´ ë³´ì´ë©´ IBSë¼ê³  ë‹¨ì • ì§“ì§€ ë§ê³  ì¶”ê°€ ê²€ì‚¬(Colonoscopy ë“±)ë¥¼ í•´ì•¼ í•©ë‹ˆë‹¤.\n- Weight loss (ì²´ì¤‘ ê°ì†Œ)\n- Blood in stool (í˜ˆë³€)\n- Nocturnal symptoms (ìë‹¤ê°€ ê¹° ì •ë„ì˜ ì„¤ì‚¬/ë³µí†µ - IBSëŠ” ë³´í†µ ìëŠ” ë™ì•ˆì€ ê´œì°®ìŒ)\n- Family Hx of Colon cancer / IBD\n- Onset age > 50 (50ì„¸ ì´í›„ ê°‘ìê¸° ìƒê¸´ ì¦ìƒ)","subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-327","focus_area":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","tags":["usmle-step2","core","diagnosis","pathophysiology"]}
